P2-274: Clinical benefits of pemetrexed 500 mg/m2 and 1000 mg/m2 in a randomized phase II study for pretreated patients with locally advanced or metastatic non–small cell lung cancer (NSCLC)
2007 ◽
Vol 2
(8)
◽
pp. S681
◽
Keyword(s):
Phase Ii
◽
2012 ◽
Vol 7
(1)
◽
pp. 157-164
◽
2007 ◽
Vol 2
(8)
◽
pp. S449-S450
◽